Syntho Chirals Profile
Key Indicators
- Authorised Capital ₹ 9.70 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.70 Cr
as on 16-11-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 26.91 Cr
as on 16-11-2024
- Satisfied Charges ₹ 32.03 Cr
as on 16-11-2024
- Revenue 1.23%
(FY 2023)
- Profit 44.99%
(FY 2023)
- Ebitda 36.40%
(FY 2023)
- Net Worth 55.59%
(FY 2023)
- Total Assets 90.35%
(FY 2023)
About Syntho Chirals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.70 Cr and a paid-up capital of Rs 9.70 Cr.
The company currently has active open charges totaling ₹26.91 Cr. The company has closed loans amounting to ₹32.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Cheemarla Reddy, Sridhar Ragi, Linga Ragi, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC043066
- Company No.
043066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Syntho Chirals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Ragi  | Managing Director | 16-Feb-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Cheemarla Reddy | Director | 22-Jun-2017 | Current |
| Sridhar Ragi | Director | 16-Jun-2005 | Current |
| Linga Ragi | Director | 15-Apr-2004 | Current |
| Anitha Ragi | Director | 29-Mar-2018 | Current |
| Aruna Ragi | Director | 29-Mar-2018 | Current |
| Ragi Reddy | Director | 12-Sep-2024 | Current |
Financial Performance of Syntho Chirals.
Syntho Chirals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.23% increase. The company also saw a substantial improvement in profitability, with a 44.99% increase in profit. The company's net worth Soared by an impressive increase of 55.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Syntho Chirals?
In 2023, Syntho Chirals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Syntho Chirals Lifesciences Private LimitedActive 12 years 2 monthsSridhar Ragi and Linga Ragi are mutual person
Vaidhatru Pharma Private LimitedActive 17 years 3 monthsCheemarla Reddy, Linga Ragi and 1 more are mutual person
- Synthovelzen Pharma Private LimitedActive 3 months 20 days
Sai Ragi and Ragi Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Mar 2022 | ₹25.96 Cr | Open |
State Bank Of India Creation Date: 01 Jun 2020 | ₹9.50 M | Open |
Axis Bank Limited Creation Date: 07 Jun 2021 | ₹25.90 Cr | Satisfied |
How Many Employees Work at Syntho Chirals?
Syntho Chirals has a workforce of 41 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Syntho Chirals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Syntho Chirals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
